SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-20-008546
Filing Date
2020-04-03
Accepted
2020-04-03 16:08:51
Documents
14

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea120229-s1_hoththerape.htm S-1 963345
2 OPINION OF SHEPPARD MULLIN RICHTER & HAMPTON LLP ea120229ex5-1_hoththera.htm EX-5.1 19699
3 OPINION OF SHEPPARD MULLIN RICHTER & HAMPTON LLP REGARDING TAX MATTERS ea120229ex8-1_hoththera.htm EX-8.1 13321
4 CONSENT OF WITHUMSMITH+BROWN, PC ea120229ex23-1_hoththera.htm EX-23.1 2573
5 GRAPHIC img_001.jpg GRAPHIC 7950
6 GRAPHIC img_002.jpg GRAPHIC 42660
7 GRAPHIC img_003.jpg GRAPHIC 178277
8 GRAPHIC img_004.jpg GRAPHIC 137291
9 GRAPHIC img_005.jpg GRAPHIC 122049
10 GRAPHIC img_006.jpg GRAPHIC 75270
11 GRAPHIC img_007.jpg GRAPHIC 22557
12 GRAPHIC img_008.jpg GRAPHIC 116391
13 GRAPHIC ex5-1_001.jpg GRAPHIC 2584
14 GRAPHIC ex8-1_001.jpg GRAPHIC 8412
  Complete submission text file 0001213900-20-008546.txt   1983701
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-237567 | Film No.: 20773409
SIC: 2834 Pharmaceutical Preparations